Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Autor: Van Hoof, Achiel, Sheliga, Adriana, Teixeira, Adriana, Tomita, Akihiro, Rocafiguera, Albert Oriol, Suvorov, Alexander, Kuzmin, Alexy, Khojasteh, Ali, Mezlini, Amel, Golenkov, Anatoly, Bosly, Andre, Belch, Andrew, Van De Velde, Ann, Illes, Árpád, Mukhopadhyay, Ashis, Meddeb, Balkis, De Prijck, Bernard, Garichochea, Bernardo, Undar, Bulent, Gabarrón, Caballero, Cao, Carmen, Souza, Carmino, Farber, Charles, Won Suh, Cheol, Burcoveanu, Cristina Ileana, Cebotaru, Cristina Ligia, Truica, Cristina-Ligia, Maruyama, Dai, Belada, David, Ben Yehuda, Dina, Udovitsa, Dmitry, Dolores, Morra, Enrica, Späth-Schwalbe, Ernst, Gonzalez-Barca, Eva, Osmanov, Evgenii, Capote, Francisco Javier, Offner, Fritz, Cardenas, Galvez, Heß, Georg, Manikhas, Georgii, Babu, Govind, Rekhtman, Grigoriy, Rossi, Guiseppe, Marques, Herlander, Bumbea, Horia, Wang, Huaqing, Huang, Huiqiang, Choi, Ilseung, Bulavina, Irina, Lysenko, Irina, Avivi, Irit, Kryachok, Iryna, Zaucha, Jan Maciej, Novak, Jan, Díaz, Joaquín, Demeter, Judit, Alexeeva, Julia, Zhu, Jun, Vilchevskaya, Kateryna, Ishizawa, Kenichi, Mauricio, Kenny, Tobinai, Kensei, Ando, Kiyoshi, Abdulkadryrov, Kudrat, Shih, Lee-Yung, Kuzina, Lyudmila, Gumus, Mahmut, De Wit, Maike, Capra, Marcelo, Marques, Margarida, Golubeva, Marina, Ojeda-Uribe, Mario, Kyselyova, Maryna, Taniwaki, Masafumi, Federico, Massimo, Crump, Michael, Baccarani, Michele, Ogura, Michinori, Egyed, Miklós, Udvardy, Miklos, Kurosawa, Mitsutoshi, Uike, Naokuni, Khuageva, Nuriet, Shpilberg, Ofer, Gladkov, Oleg, Samoilova, Olga, Serduk, Olga, Santi, Patricia, Zachee, Pierre, Kaplan, Polina, Stoia, Razvan, Gressin, Remy, Arranz, Reyes, Greil, Richard, Grosicki, Sebastian, Cancelado, Sergio, Nair, Sreejith, Le Gouill, Steven, Van Steenweghen, Steven, Yoon, Sung-Soo, Chuncharune, Suporn, Scheider, Tatiana, Shimoyama, Tatsu, Liu, Ting, Kinoshita, Tomohiro, Uchida, Toshiki, Bunworasate, Udomsak, Vitolo, Umberto, Pavlov, Viacheslav, Phooshkooru, Vijay Rao, Lima, Vladimir, Merkulov, Vladimir, Nawarawong, Weerasak, Hong, Xiaonan, Ke, Xiaoyan, Terui, Yasuhito, Tee Goh, Yeow, Maeda, Yoshiharu, Shi, Yuankai, Dunaev, Yuri, Lorie, Yurii, Wang, Zhao, Shen, Zhixiang, Borbenyi, Zita, Gasztonyi, Zoltán, Masliak, Zvenyslava, Robak, Tadeusz, Jin, Jie, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Drach, Johannes, Raderer, Markus, Mayer, Jiri, Pereira, Juliana, Tumyan, Gayane, Okamoto, Rumiko, Nakahara, Susumu, Hu, Peter, Appiani, Carlos, Nemat, Sepideh, Cavalli, Franco

Publikováno v: In The Lancet Oncology November 2018 19(11):1449-1458

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Autor: Gómez, Henry L., Neciosup, Silvia, Tosello, Célia, Mano, Max, Bines, José, Ismael, Gustavo, Santi, Patrícia X., Pinczowski, Hélio, Nerón, Yeni, Fanelli, Marcello, Fein, Luis, Sampaio, Carlos, Lerzo, Guillermo, Capó, Adolfo, Zarba, Juan J., Blajman, César, Varela, Mirta S., Martínez-Mesa, Jeovany, Werutsky, Gustavo, Barrios, Carlos H.

Publikováno v: In Clinical Breast Cancer February 2016 16(1):38-44

Applicability of modified Glasgow Prognostic Score in the assessment of elderly patients with cancer: A pilot study

Autor: Lealdini, Viviane, Trufelli, Damila Cristina, da Silva, Fernanda Borges Ferreira, Normando, Savia Raquel Costa, Camargo, Elisa Watanabe, de Matos, Leandro Luongo, Fonseca, Fernando Luiz Affonso, Santi, Patricia Xavier, Del Giglio, Auro

Publikováno v: In Journal of Geriatric Oncology November 2015 6(6):479-483

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.